NM_130439.3:c.67C>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_130439.3(MXI1):​c.67C>A​(p.Pro23Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000041 in 1,242,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000039 ( 0 hom. )

Consequence

MXI1
NM_130439.3 missense

Scores

1
2
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.37

Publications

0 publications found
Variant links:
Genes affected
MXI1 (HGNC:7534): (MAX interactor 1, dimerization protein) Expression of the c-myc gene, which produces an oncogenic transcription factor, is tightly regulated in normal cells but is frequently deregulated in human cancers. The protein encoded by this gene is a transcriptional repressor thought to negatively regulate MYC function, and is therefore a potential tumor suppressor. This protein inhibits the transcriptional activity of MYC by competing for MAX, another basic helix-loop-helix protein that binds to MYC and is required for its function. Defects in this gene are frequently found in patients with prostate tumors. Three alternatively spliced transcripts encoding different isoforms have been described. Additional alternatively spliced transcripts may exist but the products of these transcripts have not been verified experimentally. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18326259).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MXI1NM_130439.3 linkc.67C>A p.Pro23Thr missense_variant Exon 1 of 6 ENST00000332674.9 NP_569157.2 P50539-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MXI1ENST00000332674.9 linkc.67C>A p.Pro23Thr missense_variant Exon 1 of 6 1 NM_130439.3 ENSP00000331152.5 P50539-3
MXI1ENST00000453116.5 linkc.67C>A p.Pro23Thr missense_variant Exon 1 of 4 5 ENSP00000398981.1 F6U3F6
ENSG00000228417ENST00000451656.1 linkn.445G>T non_coding_transcript_exon_variant Exon 3 of 3 3
ENSG00000303571ENST00000795696.1 linkn.-51G>T upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.0000535
AC:
8
AN:
149436
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000666
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000895
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000370
AC:
1
AN:
27020
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000952
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000393
AC:
43
AN:
1092848
Hom.:
0
Cov.:
29
AF XY:
0.0000434
AC XY:
23
AN XY:
529354
show subpopulations
African (AFR)
AF:
0.0000481
AC:
1
AN:
20782
American (AMR)
AF:
0.00
AC:
0
AN:
7192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
21066
South Asian (SAS)
AF:
0.0000591
AC:
2
AN:
33868
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31642
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2728
European-Non Finnish (NFE)
AF:
0.0000391
AC:
36
AN:
920926
Other (OTH)
AF:
0.0000964
AC:
4
AN:
41508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.560
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000535
AC:
8
AN:
149546
Hom.:
0
Cov.:
31
AF XY:
0.0000411
AC XY:
3
AN XY:
73002
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41240
American (AMR)
AF:
0.0000665
AC:
1
AN:
15046
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3428
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000895
AC:
6
AN:
67030
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000567

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 18, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.67C>A (p.P23T) alteration is located in exon 1 (coding exon 1) of the MXI1 gene. This alteration results from a C to A substitution at nucleotide position 67, causing the proline (P) at amino acid position 23 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
19
DANN
Uncertain
0.99
Eigen
Benign
0.13
Eigen_PC
Benign
0.14
FATHMM_MKL
Benign
0.43
N
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.18
T;T
MetaSVM
Benign
-0.92
T
PhyloP100
1.4
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
0.050
N;N
REVEL
Benign
0.11
Sift
Benign
0.17
T;D
Sift4G
Uncertain
0.014
D;T
Polyphen
0.94
P;.
Vest4
0.33
MutPred
0.19
Gain of phosphorylation at P23 (P = 0.0042);Gain of phosphorylation at P23 (P = 0.0042);
MVP
0.14
MPC
0.65
ClinPred
0.79
D
GERP RS
3.8
PromoterAI
0.039
Neutral
gMVP
0.32
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1003982327; hg19: chr10-111967633; API